China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores, Inc.

CJJD
China Jo-Jo Drugstores, Inc.US flagNASDAQ Capital Market
1.52
USD
-0.09
- -
9.95MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
1,668.93
1,581.58
1,143.89
1,233.59
1,327.99
959
913.85
892.03
857.73
783.52
944.97
291.89
107
842.85
Basic EPS, GAAP
144.01
-253.31
-438.44
13.74
6.67
-66.42
-162.21
-7.68
-42.5
-47.79
-18.35
-41.46
-2.93
-51.41
Free Cash Flow per Basic Share
148.81
-48.03
-24.71
-32.01
34.82
13.51
-47.28
-107.09
-67.2
-3.92
-32.72
-7.05
-2.82
-4.22
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
556.16
302.35
-142.59
-118.53
-103.47
-147.98
-281.75
-253.45
-265.87
-264.25
-276.45
-135.32
-50.61
-284.26
Tangible Book Value per Share
876.17
652.91
221.23
226.06
244.34
281.84
140.78
101
104.81
117.81
105.58
25.07
7.37
126.73
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
- -
Sales/Revenue/Turnover
94
89
66
77
89
81
96
108
117
133
164
149
155
133
Operating Margin (%)
11.11
-14.06
-29.07
2.22
-0.03
-4.88
-17.1
-0.81
-5.43
-6.47
-1.55
-14.06
-2.29
-6.47
Depreciation Expense
2
3
3
3
1
1
1
2
2
2
1
1
5
2
Net Income, GAAP
8
-14
-25
1
- -
-6
-17
-1
-6
-8
-3
-21
-4
-8
Effective Tax Rate (%)
24.55
- -
- -
6.29
17.79
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
8.63
-16.02
-38.33
1.11
0.5
-6.93
-17.75
-0.86
-4.95
-6.1
-1.94
-14.2
-2.74
-6.1
Working Capital
25
15
-4
- -
5
16
8
1
4
7
1
-2
-5
7
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
23
17
9
8
6
17
Total Equity
52
38
14
17
19
27
19
17
19
24
23
17
14
24
Return on Invested Capital (%)
15.34
- -
- -
6.62
-0.06
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
26.41
- -
- -
20.16
6.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
29.74
-59.05
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'21
Dec'21
Mar'21
ST Debt
29
32
30
LT Borrowings
3
3
2
LT Finance Leases
17
18
15
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
- -
Market Capitalization
34
38
42

Working Capital

FRC

in mil. unless spec.
Sep'21
Dec'21
Mar'21
Total Current Assets
68
63
72
Cash, Cash Equivalents & STI
22
12
22
Accounts Receivable, Net
10
12
13
Inventories
13
15
17
Total Current Liabilities
58
56
65
Payables & Accruals
28
23
34
ST Debt
29
32
30
Deferred Revenue
1
1
1

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.36%
-1.43%
-14.24%
Free Cash Flow
0.76%
121.83%
13.46%
Net Income, GAAP
-41.69%
197.77%
-79.97%
Sales/Revenue/Turnover
9.38%
8.08%
3.85%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
164
2023
- -
- -
- -
- -
149
2024
- -
- -
- -
- -
155

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
-18.35
2023
- -
- -
- -
- -
-41.46
2024
- -
- -
- -
- -
-2.93

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Lei Liu
Full Time Employees
939
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Address
Hai Wai Hai Tongxin Mansion Hangzhou People's Republic of China 310008
IPO Date
Oct 1, 2009
Business
China Jo-Jo Drugstores, Inc. (CJJD) operates as a retail pharmacy chain in China, offering prescription and over-the-counter drugs, nutritional supplements, personal care products, and health services including medical consultations and vaccinations; the company also provides online pharmacy sales through its e-commerce platform and operates Jiuzhou Pharmacy Clinics for basic healthcare. Founded in 2006 and headquartered in Hangzhou, Zhejiang Province, China, it serves urban and rural customers across eastern and central China with a network of physical stores and digital channels targeting middle-income consumers seeking affordable healthcare solutions. The company competes in the pharmaceutical retail and healthcare services segment, with no publicly reported major partnerships, funding rounds, acquisitions, product launches, or strategic shifts in the last 1-2 years.

Company News

APIChatGPT
  • China Jo-Jo Drugstores Announces Strategic Business Restructuring to Strengthen Wholesale Business for Greater Profitability and Growth

  • China Jo-Jo Drugstores Reports Fiscal Year 2024 Financial Results

  • China Jo-Jo Drugstores Announces $3.37 Million Registered Direct Offering

  • China Jo-Jo Drugstores Announces Changes to Board of Directors

  • China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering

  • China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering

  • China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement

  • China Jo-Jo Drugstores, Inc. Announces 1-for-20 Reverse Stock Split

  • China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement

  • China Jo-Jo Drugstores Announces Celebration of its 20th Anniversary

  • China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering

  • Small-cap Chinese stocks spark meme-like buzz

  • Top 4 Risk Off Stocks That Are Preparing To Pump This Month

  • China Jo-Jo Drugstores stock: Avoid this dilution machine

  • Penny Stock Risk Assessment: Evaluating Potential Investments

  • 3 Investors Betting Big on China Jo-Jo Drugstores (CJJD) Stock

  • China Jo-Jo Drugstores Announces $7 Million Registered Direct Offering

  • 4 Low Float Penny Stocks To Watch This Week

  • China Jo-Jo Drugstores Selected as one of the First Batch of Four-star Livelihood Pharmaceutical Service Stations in Hangzhou

  • China Jo-Jo Drugstores Reports Fiscal Year 2021 Financial Results